tiprankstipranks
Trending News
More News >
Organogenesis Holdings (ORGO)
:ORGO
US Market

Organogenesis Holdings (ORGO) Stock Forecast & Price Target

Compare
452 Followers
See the Price Targets and Ratings of:

ORGO Analyst Ratings

Moderate Buy
2Ratings
Moderate Buy
1 Buy
1 Hold
0 Sell
Based on 2 analysts giving stock ratings to
Organogenesis
Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ORGO Stock 12 Month Forecast

Average Price Target

$5.50
▲(58.50%Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Organogenesis Holdings in the last 3 months. The average price target is $5.50 with a high forecast of $6.00 and a low forecast of $5.00. The average price target represents a 58.50% change from the last price of $3.47.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","4":"$4","7":"$7","2.5":"$2.5","5.5":"$5.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$6.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$5.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,2.5,4,5.5,7],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2024","6":"Aug<br/>2024","9":"Dec<br/>2024","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.96,5.04,5.12,5.2,5.28,5.36,5.4399999999999995,5.52,5.6,5.68,5.76,5.84,5.92,{"y":6,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.96,5.001538461538462,5.0430769230769235,5.084615384615384,5.126153846153846,5.167692307692308,5.2092307692307696,5.25076923076923,5.292307692307692,5.333846153846154,5.375384615384616,5.4169230769230765,5.458461538461538,{"y":5.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.96,4.963076923076923,4.966153846153846,4.969230769230769,4.972307692307692,4.975384615384615,4.978461538461539,4.981538461538461,4.984615384615385,4.987692307692308,4.990769230769231,4.993846153846154,4.996923076923077,{"y":5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.21,"date":1698796800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.21,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.43,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.92,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.51,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.75,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.78,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.82,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.78,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.86,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.68,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.21,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.96,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$6.00Average Price Target$5.50Lowest Price Target$5.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ORGO
TipRanks AITipRanks
Not Ranked
TipRanks
$3.5
Hold
0.86%
Upside
Reiterated
06/10/25
Organogenesis Holdings faces considerable financial and technical challenges, with declining revenue, profitability, and cash flow impacting the stock's attractiveness. Technical analysis also indicates bearish sentiment, while valuation metrics are unfavorable due to negative earnings. Despite strategic advancements and cash reserves, immediate financial issues weigh heavily on the stock's overall score.
Morgan Stanley Analyst forecast on ORGO
Patrick WoodMorgan Stanley
Morgan Stanley
$6
Hold
72.91%
Upside
Reiterated
05/27/25
Hold Rating Maintained for Organogenesis Holdings Amid Uncertainty in Coverage and Sales Projections
Lake Street Analyst forecast on ORGO
Brooks O'NeilLake Street
Lake Street
$5
Buy
44.09%
Upside
Reiterated
05/09/25
Lake Street Sticks to Its Buy Rating for Organogenesis Holdings (ORGO)
Cantor Fitzgerald Analyst forecast on ORGO
Ross OsbornCantor Fitzgerald
Cantor Fitzgerald
$6
Buy
72.91%
Upside
Reiterated
03/10/25
Oranogenesis Holdings (ORGO) PT Maintained at $6 at Cantor FitzgeraldCantor Fitzgerald analyst Ross Osborn maintained the price target on Oranogenesis Holdings (NASDAQ: ORGO) at $6.00 while maintaining a Overweight rating.
BTIG
$7
Buy
101.73%
Upside
Reiterated
03/05/25
BTIG Sticks to Its Buy Rating for Organogenesis Holdings (ORGO)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ORGO
TipRanks AITipRanks
Not Ranked
TipRanks
$3.5
Hold
0.86%
Upside
Reiterated
06/10/25
Organogenesis Holdings faces considerable financial and technical challenges, with declining revenue, profitability, and cash flow impacting the stock's attractiveness. Technical analysis also indicates bearish sentiment, while valuation metrics are unfavorable due to negative earnings. Despite strategic advancements and cash reserves, immediate financial issues weigh heavily on the stock's overall score.
Morgan Stanley Analyst forecast on ORGO
Patrick WoodMorgan Stanley
Morgan Stanley
$6
Hold
72.91%
Upside
Reiterated
05/27/25
Hold Rating Maintained for Organogenesis Holdings Amid Uncertainty in Coverage and Sales Projections
Lake Street Analyst forecast on ORGO
Brooks O'NeilLake Street
Lake Street
$5
Buy
44.09%
Upside
Reiterated
05/09/25
Lake Street Sticks to Its Buy Rating for Organogenesis Holdings (ORGO)
Cantor Fitzgerald Analyst forecast on ORGO
Ross OsbornCantor Fitzgerald
Cantor Fitzgerald
$6
Buy
72.91%
Upside
Reiterated
03/10/25
Oranogenesis Holdings (ORGO) PT Maintained at $6 at Cantor FitzgeraldCantor Fitzgerald analyst Ross Osborn maintained the price target on Oranogenesis Holdings (NASDAQ: ORGO) at $6.00 while maintaining a Overweight rating.
BTIG
$7
Buy
101.73%
Upside
Reiterated
03/05/25
BTIG Sticks to Its Buy Rating for Organogenesis Holdings (ORGO)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Organogenesis Holdings

1 Month
xxx
Success Rate
12/26 ratings generated profit
46%
Average Return
-1.51%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 46.15% of your transactions generating a profit, with an average return of -1.51% per trade.
3 Months
xxx
Success Rate
4/26 ratings generated profit
15%
Average Return
-14.58%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 15.38% of your transactions generating a profit, with an average return of -14.58% per trade.
1 Year
Success Rate
7/26 ratings generated profit
27%
Average Return
-19.27%
reiterated a buy rating 3 months ago
Copying Ryan Zimmerman's trades and holding each position for 1 Year would result in 26.92% of your transactions generating a profit, with an average return of -19.27% per trade.
2 Years
xxx
Success Rate
7/26 ratings generated profit
27%
Average Return
-26.02%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 26.92% of your transactions generating a profit, with an average return of -26.02% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ORGO Analyst Recommendation Trends

Rating
Nov 24
Dec 24
Feb 25
Mar 25
May 25
Strong Buy
2
1
2
1
2
Buy
4
3
4
4
4
Hold
2
2
2
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
6
8
7
8
In the current month, ORGO has received 6 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ORGO average Analyst price target in the past 3 months is 5.50.
Each month's total comprises the sum of three months' worth of ratings.

ORGO Financial Forecast

ORGO Earnings Forecast

Next quarter’s earnings estimate for ORGO is -$0.06 with a range of -$0.10 to -$0.01. The previous quarter’s EPS was -$0.17. ORGO beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 39.13% of the time in the same period. In the last calendar year ORGO has Outperformed its overall industry.
Next quarter’s earnings estimate for ORGO is -$0.06 with a range of -$0.10 to -$0.01. The previous quarter’s EPS was -$0.17. ORGO beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 39.13% of the time in the same period. In the last calendar year ORGO has Outperformed its overall industry.

ORGO Sales Forecast

Next quarter’s sales forecast for ORGO is $103.41M with a range of $100.70M to $106.12M. The previous quarter’s sales results were $86.69M. ORGO beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 40.81% of the time in the same period. In the last calendar year ORGO has Outperformed its overall industry.
Next quarter’s sales forecast for ORGO is $103.41M with a range of $100.70M to $106.12M. The previous quarter’s sales results were $86.69M. ORGO beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 40.81% of the time in the same period. In the last calendar year ORGO has Outperformed its overall industry.

ORGO Stock Forecast FAQ

What is ORGO’s average 12-month price target, according to analysts?
Based on analyst ratings, Organogenesis Holdings’s 12-month average price target is 5.50.
    What is ORGO’s upside potential, based on the analysts’ average price target?
    Organogenesis Holdings has 58.50% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ORGO a Buy, Sell or Hold?
          Organogenesis Holdings has a consensus rating of Moderate Buy which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Organogenesis Holdings’s price target?
            The average price target for Organogenesis Holdings is 5.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $6.00 ,the lowest forecast is $5.00. The average price target represents 58.50% Increase from the current price of $3.47.
              What do analysts say about Organogenesis Holdings?
              Organogenesis Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
                How can I buy shares of ORGO?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis